Analytical Data
-
Gene name
cap8A
- Application
-
Alternative Names
cap8A；Capsular polysaccharide type 8 biosynthesis Protein cap8A
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O15479
-
Expression Region
1-319aa
-
AA Sequence
MESTLELTKIKEVLQKNLKILIILPLLFLIISAIVTFFVLSPKYQANTQILVNQTKGDNPQFMAQEVQSNIQLVNTYKEIVKSPRILDEVSKDLNNKYSPSKLSSMLTITNQENTQLINIQVKSGHKQDSEKIANSFAKVTSKQIPKIMSLDNVSILSKADGTAVKVAPKTVVNLIGAFFLGLVVALIYIFFKVIFDKRIKDEEDVEKELGLPVLGSIQKFN
-
Molecular Weight
26.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Cap8A, a crucial protein found in certain bacterial species, has garnered significant attention in the fields of microbiology and biotechnology due to its role in conferring antibiotic resistance and its potential applications in synthetic biology. Research on Cap8A focuses on understanding its structural and functional properties, as well as its mechanism of action in bacterial stress responses. Given the rising global concern over antibiotic resistance, Cap8A serves as an important model for exploring alternative therapeutic strategies and the development of new antimicrobial agents. Additionally, its ability to be engineered for specific functions makes it a promising candidate for applications in bioremediation and bioengineering. Investigations into the genetic regulation of Cap8A expression and its interaction with other cellular pathways aim to elucidate the complex network governing bacterial resilience. With advancements in techniques such as CRISPR and protein engineering, research is striving to harness Cap8A’s properties for innovative solutions in healthcare and environmental sustainability. Overall, the continuing study of Cap8A not only deepens our understanding of bacterial physiology but also opens avenues for developing novel approaches to combat antibiotic resistance and enhance biotechnological applications.
